These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

504 related items for PubMed ID: 10678330

  • 21. Atrial fibrillation and anticoagulation.
    Garnier LF, Rouesnel P, Espitalier F.
    Arch Mal Coeur Vaiss; 2004 Oct; 97(10):1001-5. PubMed ID: 16008178
    [Abstract] [Full Text] [Related]

  • 22. [Comparative study of warfarin and aspirin for stroke prevention in elderly patients with atrial fibrillation].
    Han W, Shen DT, Wang YM.
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):851-2, 855. PubMed ID: 16793618
    [Abstract] [Full Text] [Related]

  • 23. Review: anticoagulants may be better than antiplatelet agents for nonfatal stroke but not other vascular or fatal events in nonrheumatic AF.
    Ebrahim S, Taylor F.
    ACP J Club; 2001 Jun; 135(2):A17. PubMed ID: 11571899
    [No Abstract] [Full Text] [Related]

  • 24. Atrial fibrillation and stroke prevention.
    Kakar P, Lip GY.
    Expert Rev Neurother; 2006 Oct; 6(10):1523-30. PubMed ID: 17078791
    [Abstract] [Full Text] [Related]

  • 25. [Complicated priorities regarding antithrombotic treatment of atrial fibrillation. Difficult to understand priority list in the national guidelines--new studies can make them clearer].
    Mooe T.
    Lakartidningen; 2006 Oct; 105(37):2472-3. PubMed ID: 19006861
    [No Abstract] [Full Text] [Related]

  • 26. Warfarin, aspirin, or both after myocardial infarction.
    Aronow WS.
    N Engl J Med; 2003 Jan 16; 348(3):256-7; author reply 256-7. PubMed ID: 12530434
    [No Abstract] [Full Text] [Related]

  • 27. Newer anticoagulants as an alternate to warfarin in atrial fibrillation: a changing paradigm.
    Chaudhari D, Bhuriya R, Arora R.
    Am J Ther; 2011 Jan 16; 18(1):e1-e11. PubMed ID: 20460986
    [Abstract] [Full Text] [Related]

  • 28. Primary prevention of stroke.
    Martinez-Riera A, Santolaria-Fernandez F, Gonzalez-Reimers E.
    N Engl J Med; 1996 Apr 25; 334(17):1138; author reply 1139. PubMed ID: 8598884
    [No Abstract] [Full Text] [Related]

  • 29. Better stroke prevention.
    Ornato JP.
    Health News; 2001 Apr 25; 7(4):1-2. PubMed ID: 11303474
    [No Abstract] [Full Text] [Related]

  • 30. Prevention of cardioembolic stroke in patients with atrial fibrillation.
    Weber R, Diener HC, Weimar C.
    Expert Rev Cardiovasc Ther; 2010 Oct 25; 8(10):1405-15. PubMed ID: 20936927
    [Abstract] [Full Text] [Related]

  • 31. Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.
    Hylek EM.
    Thromb Haemost; 2008 Jul 25; 100(1):16-7. PubMed ID: 18612532
    [No Abstract] [Full Text] [Related]

  • 32. A community-based educational intervention to improve antithrombotic drug use in atrial fibrillation.
    Jackson SL, Peterson GM, Vial JH.
    Ann Pharmacother; 2004 Nov 25; 38(11):1794-9. PubMed ID: 15454583
    [Abstract] [Full Text] [Related]

  • 33. Who is ineligible for warfarin in atrial fibrillation?
    Verheugt FW.
    Lancet; 2009 Aug 15; 374(9689):510-1. PubMed ID: 19683630
    [No Abstract] [Full Text] [Related]

  • 34. Aspirin versus warfarin in atrial fibrillation: decision analysis may help patients' choice.
    Romero-Ortuno R, O'Shea D.
    Age Ageing; 2012 Mar 15; 41(2):250-4. PubMed ID: 22156597
    [Abstract] [Full Text] [Related]

  • 35. Which patients with atrial fibrillation do not need anticoagulation therapy with warfarin?
    Guthmann RA.
    Am Fam Physician; 2004 Sep 01; 70(5):917-8. PubMed ID: 15368730
    [No Abstract] [Full Text] [Related]

  • 36. Preventing stroke in patients with atrial fibrillation: current treatments and new concepts.
    Connolly SJ.
    Am Heart J; 2003 Mar 01; 145(3):418-23. PubMed ID: 12660663
    [Abstract] [Full Text] [Related]

  • 37. Thromboembolic prophylaxis in nonrheumatic atrial fibrillation: utilization patterns, efficacy, and complications in a long-term follow-up of community patients.
    Blich M, Gross B.
    Int J Cardiol; 2004 Jul 01; 96(1):89-95. PubMed ID: 15203266
    [Abstract] [Full Text] [Related]

  • 38. A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO).
    Rash A, Downes T, Portner R, Yeo WW, Morgan N, Channer KS.
    Age Ageing; 2007 Mar 01; 36(2):151-6. PubMed ID: 17175564
    [Abstract] [Full Text] [Related]

  • 39. Warfarin sodium or aspirin therapy to prevent stroke in nonrheumatic atrial fibrillation. Answered and unanswered questions.
    Stratton JR.
    West J Med; 1995 Aug 01; 163(2):177-9. PubMed ID: 7571577
    [No Abstract] [Full Text] [Related]

  • 40. Antiplatelet versus anticoagulant therapies in advanced age: an unfinished task.
    García-Honrubia A, Roldán V, Climent V, Sogorb F, Marín F.
    Int J Cardiol; 2006 Jun 16; 110(2):271-2. PubMed ID: 16343666
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.